FIELD: biotechnology.
SUBSTANCE: method for the prevention of postoperative purulent complications in patients with hepatopancreatobiliary zone pathology is described. The presence of carbapenem-resistant pathogens is preliminary determined in patients with hepatopancreatobiliary system pathology by PCR method, and ceftazidim/avibactam at a dose of 2.5 g 3 times a day for 5-14 days. Ceftolosan/tazobactam at a dose of 1.5 g 3 times a day for 4-14 days are prescribed for the prevention of postoperative purulent complications in the preoperative period, if serine OXA-48 of molecular class D is indicated in 51-54% of cases, metallo-beta-lactamase VIM is indicated in 32-35% of cases, and NDM is indicated in 11-17% of cases.
EFFECT: invention increases the efficiency of prevention of postoperative purulent complications in patients with hepatopancreatobiliary system pathology.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING TUBERCULOSIS IN INFLAMMATORY INTESTINAL DISEASES | 2018 |
|
RU2712943C1 |
| METHOD FOR PREVENTING TRANSIENT HYPERLACTATEMIA IN EXTENSIVE HEPATECTOMY | 2020 |
|
RU2731606C1 |
| METHOD FOR PERCUTANEOUS TRANSHEPATIC DRAINAGE INTERVENTION IN PATIENTS WITH MECHANICAL JAUNDICE | 2019 |
|
RU2712008C1 |
| METHOD OF ULTRASOUND DIAGNOSTICS OF BILIODIGESTIVE ANASTOMOSIS STATE | 2011 |
|
RU2494675C2 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2706026C1 |
| METHOD FOR HYPOTHERMIC OXYGENATED DOUBLE MACHINE PERFUSION OF LIVER TRANSPLANT FROM POSTHUMOUS DONOR | 2023 |
|
RU2830104C1 |
| METHOD FOR TREATING NEOPLASMS OF THE MAJOR DUODENAL PAPILLA | 2022 |
|
RU2783850C1 |
| METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
| METHOD OF SURGICAL TREATMENT OF HIGH HEPATITIS CHOLEDOCHA STRUCTURES IN PATIENTS WITH FUSION OF FOUR LOBAR HEPATIC DUCTS | 2017 |
|
RU2667873C1 |
| METHOD FOR DIAGNOSING SEVERE PSEUDOMEMBRANOUS COLITIS IN PATIENTS AFTER CORONAVIRUS INFECTION | 2022 |
|
RU2786752C1 |
